206 related articles for article (PubMed ID: 15545888)
1. Melanoma metastasis to the testis demonstrated with FDG PET/CT.
Weng LJ; Schöder H
Clin Nucl Med; 2004 Dec; 29(12):811-2. PubMed ID: 15545888
[No Abstract] [Full Text] [Related]
2. A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.
Ozülker T; Ozülker F; Cicin I; Ozpaçac T
Clin Nucl Med; 2009 Dec; 34(12):948-9. PubMed ID: 20139846
[No Abstract] [Full Text] [Related]
3. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Basu S; Alavi A
Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
[No Abstract] [Full Text] [Related]
4. Melanoma imaging with highly specific PET probes: ready for prime time?
Minn H; Vihinen P
J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
[No Abstract] [Full Text] [Related]
5. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
Rehani B; Strohmeyer P; Jacobs M; Mantil J
Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
[TBL] [Abstract][Full Text] [Related]
6. PET/Computed Tomography and Patient Outcomes in Melanoma.
Rohren EM
PET Clin; 2015 Apr; 10(2):243-54. PubMed ID: 25829089
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
8. [Role of FDG PET-CT in cutaneous melanoma].
Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249
[TBL] [Abstract][Full Text] [Related]
10. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
Roarke MC; Nguyen BD; Pockaj BA
Clin Nucl Med; 2008 Aug; 33(8):562-4. PubMed ID: 18645380
[No Abstract] [Full Text] [Related]
11. Verification of musculoskeletal FDG-PET-CT findings performed for melanoma staging.
Mansour AA; Kelley MC; Hatmaker AR; Holt GE; Schwartz HS
Ann Surg Oncol; 2010 Apr; 17(4):1144-51. PubMed ID: 19967460
[TBL] [Abstract][Full Text] [Related]
12.
Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
[TBL] [Abstract][Full Text] [Related]
13. FDG PET in early stage cutaneous malignant melanoma.
McIvor J; Siew T; Campbell A; McCarthy M
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
[TBL] [Abstract][Full Text] [Related]
14. Periarticular FDG Uptake on PET/CT in malignant melanoma-metastatic or misleading?
Tan GJ; Lee ST; Berlangieri SU; Scott AM
Ann Acad Med Singap; 2013 Mar; 42(3):159-60. PubMed ID: 23604508
[No Abstract] [Full Text] [Related]
15. Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
Prakoso E; Fulham M; Thompson JF; Selby WS
Gastrointest Endosc; 2011 Apr; 73(4):750-6. PubMed ID: 21288518
[TBL] [Abstract][Full Text] [Related]
16. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Mayerhoefer ME; Prosch H; Herold CJ; Weber M; Karanikas G
Eur Radiol; 2012 Nov; 22(11):2451-7. PubMed ID: 22653282
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose-PET in the management of malignant melanoma.
Kumar R; Mavi A; Bural G; Alavi A
Radiol Clin North Am; 2005 Jan; 43(1):23-33. PubMed ID: 15693645
[TBL] [Abstract][Full Text] [Related]
19. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Abbott RA; Acland KM; Harries M; O'Doherty M
Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
